Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2010
10/19/2010US7815947 Nutritional composition for controlling blood sugar level
10/19/2010CA2469346C Substituted 2-pyrrolidin-2-yl-1h-indole derivatives for treatment of migraine
10/19/2010CA2464367C Bicyclic compounds
10/19/2010CA2463284C Pyrimidine compounds and pharmaceutical compositions containing the compounds
10/19/2010CA2451422C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
10/19/2010CA2448089C Thiolalkyl benzoic acid derivatives
10/19/2010CA2439791C Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
10/19/2010CA2437409C Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/19/2010CA2437196C A composition for the treatment of heart failure comprising levosimendan and a calcium ion source and/or an intreacellular calcium increasing agent
10/19/2010CA2429496C Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
10/19/2010CA2409743C Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/19/2010CA2390526C Sequence specific dna recombination in eukaryotic cells
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/14/2010WO2010118419A2 Novel anti-aging agents and methods to identify them
10/14/2010WO2010118330A2 Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease
10/14/2010WO2010118250A2 Methods and compositions of pi-3 kinase inhibitors for treating fibrosis
10/14/2010WO2010118034A2 Cyclic peptide analogues for non-invasive imaging of pancreatic beta-cells
10/14/2010WO2010117926A1 Substituted triazolopyridines and analogs thereof
10/14/2010WO2010117738A2 Solid state forms of sitagliptin salts
10/14/2010WO2010117370A1 Phosphate-binding magnesium salts and uses thereof
10/14/2010WO2010117342A1 A plant extract comprising statins and preparation techniques and uses thereof
10/14/2010WO2010117233A2 Stable pharmaceutical composition containing fluvastatin and method for manufacturing the same
10/14/2010WO2010117090A1 Novel isoquinolinyloxymethyl heteroaryl derivatives
10/14/2010WO2010117085A1 Aryl indole derivatives
10/14/2010WO2010117084A1 Novel isoquinoline derivatives
10/14/2010WO2010117040A1 Five-membered heterocyclic compound
10/14/2010WO2010117011A1 ANTI-Siglec-15 ANTIBODY
10/14/2010WO2010116915A1 Cyclic compound having substituted phenyl group
10/14/2010WO2010116899A1 Phosphorylation-inhibiting agent or dephosphorylating agent for pten
10/14/2010WO2010116866A1 Agent for ameliorating or preventing metabolic syndrome
10/14/2010WO2010116752A1 Neuromedin u derivative
10/14/2010WO2010116282A1 4, 5-dihydro-lh-pyrazole compounds and their pharmaceutical uses
10/14/2010WO2010116177A1 A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity
10/14/2010WO2010116176A1 Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity
10/14/2010WO2010115974A1 Crystal forms of saxagliptin
10/14/2010WO2010082072A8 Process for the preparation of rosuvastatin salts
10/14/2010WO2010080756A3 Harmine derivatives for reducing body weight
10/14/2010WO2010068918A3 Novel targets for treatment of hypercholesterolemia
10/14/2010WO2010068907A3 Compositions of proton pump inhibitors and insulin secretagogues, kits and methods of their use to treat diabetes
10/14/2010WO2010020693A3 Enzymes for the treatment of obesity
10/14/2010US20100261790 Body-weight maintenance and body composition
10/14/2010US20100261789 Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes
10/14/2010US20100261787 Pharmaceutical composition for diabetic nephropathy and its preparation and application
10/14/2010US20100261784 Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
10/14/2010US20100261773 3.3.0 BICYCLIC GlyT1 INHIBITORS AND METHODS OF MAKING AND USING SAME
10/14/2010US20100261772 Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators
10/14/2010US20100261765 Mineralocorticoid receptor modulators
10/14/2010US20100261764 Substituted 3 -hydroxypyridines and pharmaceutical compositions thereof
10/14/2010US20100261758 Heterocyclic amides for use as pharmaceuticals
10/14/2010US20100261750 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
10/14/2010US20100261743 Novel seh inhibitors and their use
10/14/2010US20100261733 Therapeutic agents 927
10/14/2010US20100261718 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261717 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261715 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
10/14/2010US20100261709 Pyridazinone derivatives as parp inhibitors
10/14/2010US20100261706 Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereof
10/14/2010US20100261704 Therapeutic agents 928
10/14/2010US20100261702 Thiophene derivatives as agonists of s1p1/edg1
10/14/2010US20100261699 N-pyrazole-2-pyridine carboxamide derivative
10/14/2010US20100261682 Method and Means for the Treatment of Cachexia
10/14/2010US20100261677 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
10/14/2010US20100261672 Pharmaceutical compositions of pyrimidine-2,4,6-triones
10/14/2010US20100261671 Inulin products with improved nutritional properties
10/14/2010US20100261670 Complexes of phosphate derivatives
10/14/2010US20100261664 Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
10/14/2010US20100261661 Compositions and methods for increasing the suppression of hunger and reducing the digestibility of non-fat energy satiety
10/14/2010US20100261645 (carboxylalkylenephenyl)phenyloxamides, method for the production thereof and use of same as a medicament
10/14/2010US20100261644 (cyclopropylphenyl)phenyloxamides, method for the production thereof, and use of same as a medicament
10/14/2010US20100261643 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical
10/14/2010US20100261642 Nutritional formulation with high energy content
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100261637 Peptides derivatized with a-b-c-d- and their therapeutical use
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100260861 Treatments with helminths
10/14/2010US20100260856 Core particle for pharmaceutical preparation
10/14/2010US20100260855 Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
10/14/2010US20100260851 Novel Polymorph of Atorvastatin Calcium and Use Thereof for the Preparation of Amorphous Atorvastatin Calcium
10/14/2010US20100260835 Pharmaceutical composition
10/14/2010US20100260816 Induction of immunological tolerance
10/14/2010US20100260811 Novel compositions of fat-soluble substances
10/14/2010US20100260781 Treatment methods for autoimmune disorders
10/14/2010US20100260771 Method for Diagnosing the Metabolic Syndrome (MS)
10/14/2010US20100260750 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
10/14/2010US20100260733 Novel anti aging agents and methods to identify them
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/2010US20100260706 Compositions and methods for improving production of recombinant polypeptides
10/14/2010US20100260669 Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
10/14/2010US20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof
10/14/2010DE102009016719A1 Composition, useful as pharmaceutical preparation for e.g. prophylaxis of lipid metabolic disorders in humans and animals and treating atherosclerosis, comprises 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor and solid material
10/14/2010CA2758271A1 Methods for preventing and/or treating lysosomal storage disorders
10/14/2010CA2758264A1 Neuromedin u derivative
10/14/2010CA2758172A1 A plant extract comprising statins and preparation techniques and uses thereof
10/14/2010CA2758144A1 Cyclic compound having substituted phenyl group
10/14/2010CA2757934A1 Crystal forms of saxagliptin
10/14/2010CA2757241A1 Solid state forms of sitagliptin salts
10/14/2010CA2756942A1 Phosphate-binding magnesium salts and uses thereof
10/14/2010CA2756272A1 Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease
10/14/2010CA2756250A1 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
10/14/2010CA2750836A1 Anti-siglec-15 antibody
1 ... 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 ... 1298